Which lab is considered a potentially superior marker of menopause?

AMH, or Anti-Müllerian Hormone, is considered a potentially superior marker of menopause because it provides insight into ovarian reserve, which decreases as women approach menopause. AMH levels reflect the quantity of remaining ovarian follicles and are typically stable throughout the menstrual cycle, making it a reliable biomarker for evaluating reproductive age and impending menopause.

As women transition to menopause, AMH levels decline significantly, often falling to undetectable levels in postmenopausal women. This decline correlates more directly with the process of ovarian aging than other hormones that can fluctuate more markedly during the menopausal transition.

In contrast, estradiol, inhibin B, and testosterone levels can vary widely throughout different stages of the menstrual cycle and may not provide as consistent or clear a picture of ovarian function during the menopausal transition. Overall, AMH serves as a more stable and reliable indicator as women approach menopause, making it a superior marker in this context.